Our News on Newswise

Newswise: donordollars-labshoot-23-1.jpeg?itok=4eCjZ0Gg

FDA Expands Orphan Drug Designation for SurVaxM, Immunotherapy Developed at Roswell Park

The FDA has expanded orphan drug designation for SurVaxM, a brain cancer immunotherapy born in the labs of Roswell Park Comprehensive Cancer Center. The supplemental designation applies to SurVaxM as treatment for not just adult glioblastoma but any...
21-Jun-2024 1:05 PM EDT Add to Favorites

Newswise: hemn-mohammadpour_landscape.jpg?itok=Bie8_nPl

Roswell Park Insights on Role of Exportin 1 Protein Suggest Strategy for Improving Cancer Immunotherapy

Research by Hemn Mohammadpour, DVM, PhD, and colleagues at Roswell Park Comprehensive Cancer Center offers new insights into tumor biology and may lay the groundwork for more effective cancer immunotherapy. Their preclinical findings were published...
20-Jun-2024 7:05 PM EDT Add to Favorites

Newswise: 66631068c2341_rpoutsidenewweb.jpg

Roswell Park Earns ‘Exceptional’ Rating from National Cancer Institute With Best-Ever Core Grant

Roswell Park Comprehensive Cancer Center has earned its most highly rated grant from the National Cancer Institute (NCI). The NCI renewed Roswell Park’s status as a Comprehensive Cancer Center - a designation held by less than 4% of cancer...
7-Jun-2024 11:45 AM EDT Add to Favorites

Newswise: 6658d9be7889c_GandhiShipraAugust062018.jpg

Study Reveals Worse Clinical Outcomes in Breast Cancer Patients Who Reported Higher Pain and Stress

Secondary analyses of a phase 3 clinical trial have revealed that breast cancer patients who reported high levels of pain and stress were more likely than their study peers to experience worse invasive disease-free survival (iDFS) and worse overall...
30-May-2024 4:25 PM EDT Add to Favorites

Newswise: 6658d8a1dbabd_AryaMariamRoyMD.jpg

Study Shows Polygenic Risk Score (PGS) Could Predict Breast Cancer Survival Outcomes

Data from a large prospective cohort study reveal that a polygenic risk score has the potential to predict survival outcomes in patients with breast cancer.
30-May-2024 4:00 PM EDT Add to Favorites

Pathways Study Genotype Data, Alliance A011502 Secondary Analysis Headline Roswell Park ASCO24 Presentations

New insights on improving clinical outcomes and quality of life among breast cancer patients highlight the slate of new research presentations Roswell Park Comprehensive Cancer Center experts will deliver at the American Society of Clinical Oncology...
24-May-2024 4:05 PM EDT Add to Favorites

Newswise: 661420322bc3c_YendamuriHeadshot2023.jpg

Roswell Park Research Debunks Perceived Benefits of Overweight/Obesity in Lung Cancer Patients

Obesity is associated with a higher risk of developing at least 13 types of cancer — and worse outcomes after diagnosis. But lung cancer seems to be an exception: Studies have shown that patients with a high body mass index (BMI) experience a...
8-Apr-2024 1:20 PM EDT Add to Favorites

Newswise: 65dcb85433e1f_fountzilasbakin.jpg

Roswell Park Study First to Show Two-Drug Combination Selectively Targets p53-Mutant Cancers

A preclinical study led by a team of researchers at Roswell Park Comprehensive Cancer Center highlights the potential of a novel two-drug treatment strategy targeting p53-mutant cancers.
26-Feb-2024 11:30 AM EST Add to Favorites

See All News

Our Experts on Newswise

Cancer-Specific Clinical Research Center: New Frontiers in Research at Roswell Park

Clinical trials are the frontier for targeted cancer drugs. Roswell Park Cancer Institute recently opened one of only a few clinical research centers in the U.S. focused exclusively on cancer. The Clinical Research Center, under the direction of...
4-Apr-2008 1:00 PM EDT

See All Experts


Roswell Park Comprehensive Cancer Center is a community united by the drive to eliminate cancer’s grip on humanity by unlocking its secrets through personalized approaches and unleashing the healing power of hope. Founded by Dr. Roswell Park in 1898, it is the only National Cancer Institute-designated comprehensive cancer center in Upstate New York. Learn more at www.roswellpark.org, or contact us at 1-800-ROSWELL (1-800-767-9355) or [email protected].